Two recent clinical studies do not support the use of dopamine D1/5 antagonists in cocaine abuse July 27, 2001
Xenova receives FDA approval to resume clinical trials with anticocaine addiction vaccine July 10, 2001
Phase II Naltrel data for alcohol and heroin addiction presented at Drug Dependence meeting June 21, 2001
Antizol for methanol poisoning granted orphan drug status in E.C., priority review in Canada June 15, 2001
Oral iron chelator from Novartis and implications for the therapy of transfusional iron overload May 3, 2001
Southern Research Institute presents preparation and uses of new compounds derived from naltrexone April 4, 2001